E. Pencreach

发表

Gene Expression Classification of Colon Cancer into Molecular Subtypes: Characterization, Validation, and Prognostic Value

Mira Ayadi, Pierre Laurent-Puig, Aurélien de Reyniès, 2013, PLoS medicine.

Dynamic Evolution of Clonal Composition and Neoantigen Landscape in Recurrent Metastatic Melanoma with a Rare Combination of Driver Mutations.

D. Lipsker, G. Malouf, I. Davidson, 2019, The Journal of investigative dermatology.

Human Papillomavirus-related tumours of the oropharynx display a lower tumour hypoxia signature.

B. Wasylyk, J. Abecassis, M. Suarez-Carmona, 2015, Oral oncology.

Characterization of the transcriptional and metabolic responses of pediatric high grade gliomas to mTOR-HIF-1a axis inhibition.

E. Letouzé, B. Lhermitte, Chris Jones, 2017, Oncotarget.

Hypoxia differentially regulated CXCR4 and CXCR7 signaling in colon cancer

Muriel Hachet-Haas, J. Galzi, M. Gaub, 2014, Molecular Cancer.

Synthetic polyamines promote rapid lamellipodial growth by regulating actin dynamics

D. Riveline, J. Lehn, M. Carlier, 2013, Nature Communications.

Constitutive or Induced HIF-2 Addiction is Involved in Resistance to Anti-EGFR Treatment and Radiation Therapy in HNSCC

E. Pencreach, J. Jegu, C. Gaiddon, 2019, Cancers.

The EXTREME Regimen Associating Cetuximab and Cisplatin Favors Head and Neck Cancer Cell Death and Immunogenicity with the Induction of an Anti-Cancer Immune Response

C. Borel, E. Pencreach, V. Devignot, 2022, Cells.

Engineering Novel 3D Models to Recreate High‐Grade Osteosarcoma and its Immune and Extracellular Matrix Microenvironment

B. Lhermitte, A. Klymchenko, M. Dontenwill, 2022, Advanced healthcare materials.

Synergistic Anti-Tumor Effect of mTOR Inhibitors with Irinotecan on Colon Cancer Cells

E. Guérin, D. Guenot, E. Pencreach, 2019, Cancers.

Allelotyping analyses of synchronous primary and metastasis CIN colon cancers identified different subtypes

P. Bachellier, D. Jaeck, M. Gaub, 2007, International journal of cancer.

Independent prognostic value of ultra-sensitive quantification of tumor pre-treatment T790M subclones in EGFR mutated non-small cell lung cancer (NSCLC) treated by first/second generation TKI, depends on variant allele frequency (VAF): Results of the French cooperative thoracic intergroup (IFCT) bio

H. Blons, J. Merlio, F. Escande, 2019, Lung cancer.

Direct Targeting KRAS Mutation in Non-Small Cell Lung Cancer: Focus on Resistance

C. Mascaux, E. Guérin, L. Vallat, 2022, Cancers.

Molecular Mechanism of EGFR-TKI Resistance in EGFR-Mutated Non-Small Cell Lung Cancer: Application to Biological Diagnostic and Monitoring

C. Mascaux, E. Guérin, L. Vallat, 2021, Cancers.

Marked Activity of Irinotecan and Rapamycin Combination toward Colon Cancer Cells In vivo and In vitro Is Mediated through Cooperative Modulation of the Mammalian Target of Rapamycin/Hypoxia-Inducible Factor-1α Axis

M. Gaub, A. Larsen, E. Guérin, 2009, Clinical Cancer Research.

Hypoxia differentially regulated CXCR4 and CXCR7 signaling in colon cancer

J. Galzi, M. Gaub, C. Brigand, 2014, Molecular Cancer.

SFCE-RAPIRI Phase I Study of Rapamycin Plus Irinotecan: A New Way to Target Intra-Tumor Hypoxia in Pediatric Refractory Cancers

N. André, D. Frappaz, B. Lhermitte, 2020, Cancers.

SNAI2 and TWIST1 in lymph node progression in early stages of NSCLC patients

E. Guérin, E. Quoix, M. Chenard, 2018, Cancer medicine.

All pineal tumors expressing germ cell tumor markers are not necessarily germ cell tumors: histopathological and molecular study of a midline primary intracranial sarcoma DICER1-mutant

P. Varlet, B. Lhermitte, M. Chenard, 2022, Virchows Archiv.

Role of Topoisomerases in Pediatric High Grade Osteosarcomas: TOP2A Gene Is One of the Unique Molecular Biomarkers of Chemoresponse

M. Gaub, E. Guérin, D. Guenot, 2013, Cancers.

Simultaneous Development of Lymphoma in Recipients of Renal Transplants from a Single Donor: Donor Origin Confirmed by Human Leukocyte Antigen Staining and Microsatellite Analysis

M. Gaub, T. Hannedouche, L. Braun, 2005, Transplantation.

Histone hypoacetylation contributes to CXCL12 downregulation in colon cancer: impact on tumor growth and cell migration

L. Marisa, L. Poidevin, J. Freund, 2017, Oncotarget.

Prognostic and Predictive Biomarkers in the Era of Immunotherapy for Lung Cancer

C. Mascaux, M. Beau-Faller, E. Pencreach, 2023, International journal of molecular sciences.

Characterization of the transcriptional and metabolic responses of pediatric high grade gliomas to mTOR-HIF-1α axis inhibition

E. Letouzé, B. Lhermitte, Chris Jones, 2017, Oncotarget.

p16 Immunohistochemical Expression as a Surrogate Assessment of CDKN2A Alteration in Gliomas Leading to Prognostic Significances

B. Lhermitte, H. Cebula, E. Guérin, 2023, Cancers.

In Vivo Topoisomerase I Inhibition Attenuates the Expression of Hypoxia-Inducible Factor 1α Target Genes and Decreases Tumor Angiogenesis

Olivier Poch, Wolfgang Raffelsberger, Eric Guérin, 2012, Molecular medicine.

Laminin α1 orchestrates VEGFA functions in the ecosystem of colorectal carcinoma

P. Shankaranarayanan, N. Ambartsumian, M. Kedinger, 2017, bioRxiv.

Increasing the oxygen load by treatment with myo-inositol trispyrophosphate reduces growth of colon cancer and modulates the intestine homeobox gene Cdx2

M. Aprahamian, C. Nicolau, J. Freund, 2013, Oncogene.

Patient-Derived Tumoroid for the Prediction of Radiotherapy and Chemotherapy Responses in Non-Small-Cell Lung Cancer

N. Benkirane-Jessel, F. Fioretti, V. Lindner, 2023, Biomedicines.

Frequent factor II G20210A mutation in idiopathic portal vein thrombosis.

M. Gaub, R. Baumann, P. Dufour, 1999, Gastroenterology.

Modification of topoisomerase genes copy number in newly diagnosed childhood acute lymphoblastic leukemia

M. Gaub, E. Guérin, N. Entz-Werlé, 2003, Leukemia.

Primary tumour genetic alterations and intra‐tumoral heterogeneity are maintained in xenografts of human colon cancers showing chromosome instability

S. Manoir, M. Gaub, C. Brigand, 2006, The Journal of pathology.